Shpack Landfill (FUSRAP Site) Norton, MA (5 acre site)

Schpack Landfill Schpack Landfill
		Shpack Landfill (FUSRAP Site) Norton, MA (5 acre site) The Shpack Landfill is located about 65 kilometers (40 miles) southwest of Boston in the towns of Norton and Attleboro, Massachusetts. The landfill began operating in the 1960s as a landfill for both industrial and domestic wastes. The landfill was closed under court-order in the mid-1960s. In the late 1970s a concerned citizen who detected elevated radiation levels at the site contacted the Nuclear Regulatory Commission. It was confirmed that there was radioactivity present that was above acceptable limits and probably originated from activities performed by Texas Instruments (formerly known as M&C Nuclear, Inc.). The landfill contains wastes that are contaminated with high-enriched uranium, low-enriched uranium, natural uranium, depleted uranium, radium and various chemicals. Macroscopic amounts of high-enriched uranium and other radioactive materials were removed during a 1980�s survey by Oak Ridge personnel. The site was part of the Formerly Utilized Sites Remedial Action Program (FUSRAP). The FUSRAP Program was transferred to the United States Army Corps of Engineers (USACE) in 1997 in accordance with the Energy and Water Development Appropriations Act for FY 1998.

Congressman Joe Kennedy sponsored town hall style meeting for Former TI employees

BY STEPHEN PETERSON SUN CHRONICLE 

ATTLEBORO - More than 100 former Metals & Controls and Texas Instruments workers and family members attended a forum Friday night to continue to deal with a legacy from the Cold War.

The session, held at Bristol Community College on the site of the former Metals & Controls plant, was intended to inform those who gathered about federal compensation programs available for workers and families of workers who may have contracted cancer from working with radioactive materials.

Thousands worked at the industrial complex, which manufactured nuclear fuel for the Navy and other customers, from 1952 to 1967, and hundreds have been diagnosed with cancer.

While only a small part of the plant was used for nuclear manufacturing, the Attleboro site has been classified by the federal government as a former "atomic weapons employer." Fuel manufactured at the site was used in nuclear submarines and government research reactors.

U.S. Rep. Joseph Kennedy III, D-Newton, and the U.S. Labor Department spearheaded the forum, and there was also a representative of the National Institute of Occupational Safety and Health.

Lance Lanier from the Cleveland office of the Department of Labor detailed the Energy Employees Occupational Illness Compensation Program.

A program for contractors and subcontractors of the Department of Energy that pays up to $150,000 to victims of 22 cancers was created in 2000.

Larry Darcey, a former TI manager who lives in Rehoboth and who helped spark awareness of the cancer issue, said he runs across many ex-workers with multiple cancers.

Mathew Savastano, 82, of Attleboro, said he worked for the company from 1956 to 1966, beginning in his mid-20s, and began suffering from asthma at age 40. He said he has had blood clots in his lungs and several bouts of pneumonia and been "in and out of the hospital."

"I worked on nuclear reactors, did the wiring," Savastano said, adding he was in contact with radioactive enriched uranium and once broke out in a rash that led him to being written up in a medical journal. "I got all of these residual medical problems. It doesn't seem fair they only cover" cancer.

Another program that provides money for any condition linked to exposure to toxic substances went into effect in 2004, Lanier said.

While nuclear work at TI stopped in 1967, residual radiation is believed to have remained until 1997, when the site was cleaned of contamination, officials said. They said there was no monitoring of radiation levels during the nuclear years but there was afterward.

Lanier acknowledged many workers likely became sick from working with toxic metals and chemicals as well.

Texas Instruments sold its Attleboro-based business in 2005, and Darcey said he would like to see coverage extend up to that time.

"We will investigate to see what we can do to broaden some of these categories" for coverage, Kennedy said.

Kenneth Collins, 75, of Swansea, said he worked at the plant in the early 1960s and his father William worked from 1954 to 67, dying of mouth and nose cancer in 1988. "Why did the government wait so long?" Collins asked, highlighting the lack of medical records.

One woman said her father is suffering from bone cancer and wondered if the application would go through before he died. "If it is terminal, we try to speed up the claims," Lanier said.

William Bourque, 82, of Taunton, worked at the plant from 1953 to 1989, and was in contact with nuclear materials for eight years from the mid-50s to mid-60s. He said he once had a piece of uranium stuck in him for months. "I did every job in a highly contaminated area," Bourque said, adding he was "proud" to do the work for the U.S.

The Sun Chronicle documented in a series of reports that more than 300 former workers suffering from cancer received about $30 million in payments and medical benefits under the Labor Department compensation program.

However, the newspaper found little was done to reach out to ex-employees. Kennedy raised the issue at a congressional hearing and received a pledge by Texas Instruments to contact former workers, and the company sent out more than 2,000 letters about the compensation program.

Although a representative from TI was not available for Friday's forum, Lanier said his department has been getting good cooperation from the company. "That is very rare," he said, adding they have employment records.

"We have gotten quite a few claims the last few months," Lanier said.

For more information, workers and families are advised to visit the Department of Labor online, and/or call 1-800-941-3943 or Kennedy's Attleboro office representative Lisa Nelson at 508-431-1110

Where did the list of 22 "specified cancers" for the SEC come from?

Where did the list of 22 "specified cancers" for the SEC come from? 

Did NIOSH develop this list?

Neither NIOSH nor the Advisory Board on Radiation and Worker Health developed the list of 22 "specified cancers," and neither can modify the list. The list is part of the EEOICPA statute, and only Congress can modify the list of "specified cancers." The origin for the list of "specified cancers" began in the Radiation-Exposed Veterans Compensation Act (REVCA) of 1988. The Radiation-Exposed Veterans Compensation Act's original list included 13 cancers that were based on published reports from National Research Council Committees that identified elevated risks of contracting these cancers after exposure to radiation. This list of 13 cancers was then incorporated into the original enactment of the Radiation Exposure Compensation Act in 1990. In 2000, the Radiation Exposure Compensation Act was amended to incorporate a variety of changes, including the addition of 6 more specified cancers. The list of "specified cancers" for inclusion in the SEC is comprised of 22 cancers: 19 cancers specified in RECA; renal and bone cancers as specified in EEOICPA; and male and female breast cancers, which are considered separately under EEOICPA.

The following table shows a comparison of the "specified cancers" under the Radiation Exposure Compensation Act, the Radiation-Exposed Veterans Compensation Act, and EEOICPA.

Comparison of "Specified Cancer" Lists¹

Cancer site	REVCA and RECA (1990)	RECA (2000)2	EEOICPA
Bile duct	X	X	X
Bone			X
Brain		X	X
Breast (female and male)	X	X	X
Colon		X	X
Esophagus	X	X	X
Gall bladder	X	X	X
Kidney			X
Leukemia (exc. CLL)	X	X	X
Liver	X	X	X
Lung		X	X
Lymphoma (NHL)	X	X	X
Multiple myeloma	X	X	X
Ovary		X	X
Pancreas	X	X	X
Pharynx	X	X	X
Salivary gland		X	X
Small intestine	X	X	X
Stomach	X	X	X
Thyroid	X	X	X
Urinary bladder		X	X

¹This table is provided for comparison purposes only and does not include other requirements that might apply, such as latency period and primary and tumor status (i.e., primary or secondary).

²This list is specifically for those cancers covered by RECA under open- air nuclear testing.

Out in the Cold - America's Cold War Veterans

Out in the Cold - America's Cold War Veterans

They are America's Cold War veterans, who forged weapons from a fearsome energy source and bravely endured years of radiation for a country that pledged to take care of them. Instead, government loopholes and evasions are making sure those promises are never kept.

EEOICPA's purpose is to recognize that nuclear weapons workers with any of 22 kinds of cancers (among them breast, colon, bladder, brain, and non-Hodgkin's lymphoma) are likely to have gotten their illnesses on the job, and that poor record keeping or gross health-safety negligence make it difficult to know exactly who was exposed, and to what extent. EEOICPA says that former weapons workers who are "at least as likely as not" to have gotten cancer from radiation are entitled to medical benefits and a lump-sum payment of $150,000. The law is an antidote to the legal action that workers might otherwise have to take, at their own expense, if they believe they are entitled to worker's comp. A hundred and fifty grand's not exactly pay dirt for people who've drained their bank accounts, taken out loans, or gone bankrupt fighting cancer. But, if nothing else, the measure was a gesture of appreciation. EEOICPA let workers believe that the government's heart was in the right place.

Seven years after the law passed, the crowd of Rocky Flats workers at the Westin saw a government that was heartless. As far as the Flats brothers and sisters were concerned, their piece of star-spangled legislation had been designed with loopholes and engineered to fail them. By now they had learned that EEOICPA was undermined by "dose reconstruction," a procedure that seemed more black magic than sound science.

Dose reconstruction is the responsibility of the National Institute for Occupational Safety and Health, or NIOSH. To reconstruct a radiation dose, NIOSH digs up whatever it can about a claimant—urinalysis, nasal swab results, medical files, DOE "incident" reports, dosimetry records, and personal histories. And therein lies the problem: Like Judy and Tom, everyone has a story. The more time I spent talking to former Rocky Flats employees, the more anecdotes I heard about faulty dosimeters and dubious orders. Two former government officials insisted that medical records "disappeared" during the 1989 FBI raid. A former administrative assistant says she was ordered to illegally shred workers' medical records in the 1990s. Some people I spoke to were still shackled by the culture of secrecy; when I'd press them for details, they'd clam up. One man simply quit talking to me the moment I opened my notebook. Despite overwhelming consistencies among workers' stories of questionable health safety, only a fraction of what they say can be corroborated. It's their word. None of them had the foresight to build a case history while they were producing bombs, cleaning up an environmental disaster, and tending to their lives. And the government's dose reconstruction program dismisses almost any anecdote that a worker cannot prove.

When a claimant's records are missing or incomplete, NIOSH will use "coworker data"—records from a colleague who performed a similar job at a similar point in time. NIOSH also refers to a "site profile"—a multipage report that the agency has created for some of the 79 weapons facilities in the United States, that summarizes which parts of a site were most radioactive, and when. (Site profiles do not exist for all facilities.) In the end, the hard data get sent to the Department of Labor, plugged into a "matrix," and tallied to determine a figure known as "probability of causation," or POC. The POC is the claimant's final score; it informs Labor if the claimant was "at least as likely as not" to have gotten cancer due to work at a nuclear weapons facility. Claimants with a POC of 50 percent or higher are compensated. Claimants with a POC of 49.99 percent or lower are not.

Judy Padilla applied for compensation in August 2001—and waited nearly four years for a response. Her dose reconstruction score was 42.19; she was denied. She appealed the decision to the Department of Labor, explaining that she'd worked around ionizing radiation for the better part of 14 years, and that six of those years were spent chest-to-glove box, handling plutonium. Seven of her remaining eight years, she reminded the DOL, were spent working with thorium-equipped welding gear and completing tasks in the process areas. Like her coworkers, she'd seen or been near more fires and spills and accidents—some reported, some not—than she could count. She was a healthy, exercising nonsmoker, and two genetic tests showed no history of breast cancer in her family. Judy's appeal was denied.

Tom Haverty applied in July 2006. DOL still hasn't issued a decision, but a NIOSH worker recently told him that his prospects weren't good. Speaking by phone, the representative, Brian, told Tom he couldn't give specifics, but he indicated that Tom's score was less than 50. He said that Tom's final answer from DOL could take another eight months. Tom matter of factly stated that he'd likely be dead by then. Brian delivered news to Tom with the detached aplomb of an airline gate agent telling a passenger that his flight's been cancelled. It was clear that Brian had done this before.

Nearly 3,000 Rocky Flats workers have applied for compensation under this portion of EEOICPA; only 626, or 20 percent, have been paid. More than 69,000 weapons workers (or their families) across the country have submitted claims; at least one-third of them have been denied. The reason for their denials boils down to the dose reconstruction results—meaning they couldn't prove that they were "at least as likely as not" to have gotten cancer from radiation. They were given the burden of proof.

Larry Elliott oversees NIOSH's dose reconstruction program, and he defends his agency's work. "What most people don't understand is that dose reconstruction is an accepted scientific program to fill data gaps," he recently told me. "A high percentage of Rocky Flats workers have monitoring records, and NIOSH has those records." But, he went on, not all people were monitored. "We do not have individual monitoring records for every worker." He spoke of "unknown primaries" and "upper ranges." He assured me that dose reconstruction was set up to be as "claimant favorable" as possible.

Outside of NIOSH, it's tough to find anyone who supports the way the agency applies dose reconstruction. Richard Miller has worked as a senior policy analyst for the D.C. watchdog group Government Accountability Project and as a staff representative for DOE employees. Just last year, testifying before a House Judiciary Subcommittee, he said glove-box workers handling radiation at Rocky Flats (and other sites around the country) "were not adequately shielded for many years...[dosimeter] readings did not necessarily capture the neutron dose from leaky glove boxes, since the badges were not positioned near the parts of the glove box that leaked radiation." Tom Haverty's translation: "Radiation can blow up your skirt. It can radiate your skull. We wore dosimeters around our necks, not on our heads."

Even champions of the EEOICPA law acknowledge that the process of dose reconstruction is debatable. They point out that this particular brand of science was originally modeled to study large, unmonitored populations, like survivors of Hiroshima and Nagasaki, who were exposed to a single big blast, or atomic veterans who were involved in early weapons testing—not individuals who were exposed to low levels of radiation over long periods of time.

"When the bill was written, people on the Hill knew that any kind of science was imperfect—the law was even amended a few times to try to address that," Cindy Blackston, a former Judiciary staffer intimate with EEOICPA, recently told me. "But science is only as good as the perspective of the individual interpreting it. Some people within the system have interpreted the law so that claimants are placed on the defensive—which is exactly what the law was supposed to remedy. In many cases, the good intentions of EEOICPA have been abandoned."

Radiation Exposure and Cancer

The associations between radiation exposure and cancer are mostly based on populations exposed to relatively high levels of ionizing radiation (e.g., Japanese atomic bomb survivors and recipients of selected diagnostic or therapeutic medical procedures). Cancers associated with high dose exposure include leukemia, breast, bladder, colon, liver, lung, esophagus, ovarian, multiple myeloma, and stomach cancers. Literature from the U.S. Department of Health and Human Services also suggests a possible association between ionizing radiation exposure and prostate, nasal cavity/sinus, pharyngeal and laryngeal, and pancreatic cancers.

Those cancers that may develop as a result of radiation exposure are indistinguishable from those that occur naturally or as a result of exposure to other chemical carcinogens. Furthermore, literature from the National Cancer Institute indicates that other chemical and physical hazards and lifestyle factors (e.g., smoking, alcohol consumption, and diet) significantly contribute to many of these same diseases.

Although radiation may cause cancer at high doses and high dose rates, public health data do not absolutely establish the occurrence of cancer following exposure to low doses and dose rates — below about 10,000 mrem (100 mSv). Studies of occupational workers who are chronically exposed to low levels of radiation above normal background have shown no adverse biological effects. Even so, the radiation protection community conservatively assumes that any amount of radiation may pose some risk for causing cancer and hereditary effect, and that the risk is higher for higher radiation exposures.

A linear no-threshold (LNT) dose-response relationship is used to describe the relationship between radiation dose and the occurrence of cancer. This dose-response model suggests that any increase in dose, no matter how small, results in an incremental increase in risk. The U.S. Nuclear Regulatory Commission (NRC) accepts the LNT hypothesis as a conservative model for estimating radiation risk.

Biological Effects of Radiation

Biological Effects of Radiation

Radiation is all around us. It is naturally present in our environment and has been since the birth of this planet. Consequently, life has evolved in an environment which has significant levels of ionizing radiation. It comes from outer space (cosmic), the ground (terrestrial), and even from within our own bodies. It is present in the air we breathe, the food we eat, the water we drink, and in the construction materials used to build our homes. Certain foods such as bananas and brazil nuts naturally contain higher levels of radiation than other foods. Brick and stone homes have higher natural radiation levels than homes made of other building materials such as wood. Our nation's Capitol, which is largely constructed of granite, contains higher levels of natural radiation than most homes.

Levels of natural or background radiation can vary greatly from one location to the next. For example, people residing in Colorado are exposed to more natural radiation than residents of the east or west coast because Colorado has more cosmic radiation at a higher altitude and more terrestrial radiation from soils enriched in naturally occurring uranium. Furthermore, a lot of our natural exposure is due to radon, a gas from the earth's crust that is present in the air we breathe.

About half of the total annual average U.S. individual’s radiation exposure comes from natural sources. The other half is mostly from diagnostic medical procedures. The average annual radiation exposure from natural sources is about 310 millirem (3.1 millisieverts or mSv). Radon and thoron gases account for two-thirds of this exposure, while cosmic, terrestrial, and internal radiation account for the remainder. No adverse health effects have been discerned from doses arising from these levels of natural radiation exposure.

Man-made sources of radiation from medical, commercial, and industrial activities contribute about another 310 mrem to our annual radiation exposure. One of the largest of these sources of exposure is computed tomography (CT) scans, which account for about 150 mrem. Other medical procedures together account for about another 150 mrem each year. In addition, some consumer products such as tobacco, fertilizer, welding rods, exit signs, luminous watch dials, and smoke detectors contribute about another 10 mrem to our annual radiation exposure.

The pie chart on the following page shows a breakdown of radiation sources that contribute to the average annual U.S. radiation dose of 620 mrem. Nearly three-fourths of this dose is split between radon/thoron gas and diagnostic medical procedures. Although there is a distinction between natural and man-made radiation, they both affect us in the same way.

Above background
levels of radiation
exposure, the NRC
requires that its
licensees limit
maximum radiation
exposure to individual
members of the public
to 100 mrem (1mSv)
per year, and limit
occupational radiation
exposure to adults
working with
radioactive material to
5,000 mrem (50 mSv)
per year. NRC
regulations and
radiation exposure limits are contained in Title 10 of the Code of Federal Regulations, Part 20.

Biological Effects of Radiation

We tend to think of biological effects of radiation in terms of their effect on living cells. For low levels of radiation exposure, the biological effects are so small they may not be detected. The body has repair mechanisms against damage induced by radiation as well as by chemical carcinogens. Consequently, biological effects of radiation on living cells may result in three outcomes: (1) injured or damaged cells repair themselves, resulting in no residual damage; (2) cells die, much like millions of body cells do every day, being replaced through normal biological processes; or (3) cells incorrectly repair themselves resulting in a biophysical change.

The associations between radiation exposure and the development of cancer are mostly based on populations exposed to relatively high levels of ionizing radiation (e.g., Japanese atomic bomb survivors, and recipients of selected diagnostic or therapeutic medical procedures). Cancers associated with high-dose exposure (greater than 50,000 mrem) include leukemia, breast, bladder, colon, liver, lung, esophagus, ovarian, multiple myeloma, and stomach cancers. Department of Health and Human Services literature also suggests a possible association between ionizing radiation exposure and prostate, nasal cavity/sinuses, pharyngeal and laryngeal, and pancreatic cancer.

The period of time between radiation exposure and the detection of cancer is known as the latent period and can be many years. Those cancers that may develop as a result of radiation exposure are indistinguishable from those that occur naturally or as a result of exposure to other carcinogens. Furthermore, National Cancer Institute literature indicates that other chemical and physical hazards and lifestyle factors (e.g., smoking, alcohol consumption, and diet) contribute significantly to many of these same diseases.

Although radiation may cause cancers at high doses and high dose rates, currently there are no data to establish unequivocally the occurrence of cancer following exposure to low doses and dose rates – below about 10,000 mrem (100 mSv).

Even so, the radiation protection community conservatively assumes that any amount of radiation may pose some risk for causing cancer and hereditary effect, and that the risk is higher for higher radiation exposures. A linear, no-threshold (LNT) dose response relationship is used to describe the relationship between radiation dose and the occurrence of cancer. This dose-response hypothesis suggests that any increase in dose, no matter how small, results in an incremental increase in risk. The LNT hypothesis is accepted by the NRC as a conservative model for determining radiation dose standards, recognizing that the model may over estimate radiation risk.

High radiation doses tend to kill cells, while low doses tend to damage or alter the genetic code (DNA) of irradiated cells. High doses can kill so many cells that tissues and organs are damaged immediately. This in turn may cause a rapid body response often called Acute Radiation Syndrome. The higher the radiation dose, the sooner the effects of radiation will appear, and the higher the probability of death. This syndrome was observed in many atomic bomb survivors in 1945 and emergency workers responding to the 1986 Chernobyl nuclear power plant accident. Approximately 134 plant workers and firefighters battling the fire at the Chernobyl power plant received high radiation doses – 80,000 to 1,600,000 mrem (800 to 16,000 mSv) – and suffered from acute radiation sickness. Of these, 28 died within the first three months from their radiation injuries. Two more patients died during the first days as a result of combined injuries from the fire and radiation.

Because radiation affects different people in different ways, it is not possible to indicate what dose is needed to be fatal. However, it is believed that 50% of a population would die within thirty days after receiving a dose of between 350,000 to 500,000 mrem (3500 to 5000 mSv) to the whole body, over a period ranging from a few minutes to a few hours. This would vary depending on the health of the individuals before the exposure and the medical care received after the exposure. These doses expose the whole body to radiation in a very short period of time (minutes to hours). Similar exposure of only parts of the body will likely lead to more localized effects, such as skin burns.

Conversely, low doses – less than 10,000 mrem (100 mSv) – spread out over long periods of time (years) don't cause an immediate problem to any body organ. The effects of low doses of radiation, if any, would occur at the cell level, and thus changes may not be observed for many years (usually 5-20 years) after exposure.

Genetic effects and the development of cancer are the primary health concerns attributed to radiation exposure. The likelihood of cancer occurring after radiation exposure is about five times greater than a genetic effect (e.g., increased still births, congenital abnormalities, infant mortality, childhood mortality, and decreased birth weight). Genetic effects are the result of a mutation produced in the reproductive cells of an exposed individual that are passed on to their offspring. These effects may appear in the exposed person's direct offspring, or may appear several generations later, depending on whether the altered genes are dominant or recessive.

Although radiation-induced genetic effects have been observed in laboratory animals (given very high doses of radiation), no evidence of genetic effects has been observed among the children born to atomic bomb survivors from Hiroshima and Nagasaki.

NRC regulations strictly limit the amount of radiation that can be emitted by a nuclear facility, such as a nuclear power plant. A 1991 study by the National Cancer Institute, “Cancer in Populations Living Near Nuclear Facilities,” concluded that there was no increased risk of death from cancer for people living in counties adjacent to U.S. nuclear facilities. At the NRC’s request, the National Academy of Sciences is currently engaged in a state-of-the-art update to the earlier study. The new study will examine cancer rates in communities around operating and decommissioned nuclear power plants, as well as nuclear fuel cycle facilities.